Moving Precision Medicine into Clinical Care and Health Policies: UCSF, Stanford, and Beyond
Precision medicine has evolved from a distant promise to reality, with many genomic tests now used in clinical care. Dr. Phillips will discuss the opportunities for researchers and clinicians to address the health policy implications of precision medicine, with a particular focus on opportunities at UCSF and Stanford. She will discuss a case study of a recent and highly controversial CMS national coverage decision on sequencing tests for cancer patients based on her article in JAMA 4/16/2018 (Phillips KA. Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?)
Kathryn A. Phillips, PhD
Professor of Health Economics and Health Services Research and Founding Director, UCSF Center for Translational and Policy Research on Personalized Medicine University of California, San Francisco
Kathryn Phillips’s expertise is in the implementation of new technologies to improve healthcare. In 2007, she founded the UCSF Center for Translational and Policy Research on Personalized Medicine, which focuses on how to develop objective evidence on value and payer coverage of precision/personalized medicine. Dr. Phillips has published ~150 articles in major journals, including JAMA, New England Journal of Medicine, and Health Affairs, and has had continuous funding from the NIH as a Principal Investigator for 25 years. She serves on the editorial boards of the journals Health Affairs and Value in Health as well as all of the leading journals on precision medicine. A distinguishing characteristic of Dr. Phillips’ work is the translation of science into policy by bringing together perspectives across stakeholders. She has worked extensively with health plans, industry, and government agencies across the globe and has served on national and international scientific advisory committees for the National Academy of Medicine, Food and Drug Administration, and the President’s Council of Advisors on Science and Technology. Dr. Phillips is now serving on the Board of Directors for GenomeCanada (a non-profit organization that oversees and funds genomic research in Canada). In 2016, she was awarded a Rockefeller Foundation Bellagio Residency to pursue her work from a global perspective. Dr. Phillips holds degrees from UC-Berkeley, Harvard, and UT-Austin.
Lunch will be provided to those who register.